Syndax Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Syndax Pharmaceuticals, Inc.‘s stocks are currently a part of 90 hedge funds’ portfolios, which represents 43.18% of the total amount of its stocks outstanding. This makes up a total of 26.23M shares of Syndax Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -63.23% or -45.12M shares fewer. As for the holding position changes, 46.67% (42) of current hedge fund investors increased the number of shares held, 16.67% (15) of current holders sold a part of the shares held, and 14.44% (13) closed the holdings completely. 18 hedge funds are new holders of Syndax Pharmaceuticals, Inc. stock in Q1 2023, it is 20% of total holders.
Hedge funds holding Syndax Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 83 |
|---|---|
| Q3 2018 | 74 |
| Q4 2018 | 73 |
| Q1 2019 | 67 |
| Q2 2019 | 70 |
| Q3 2019 | 71 |
| Q4 2019 | 71 |
| Q1 2020 | 82 |
| Q2 2020 | 96 |
| Q3 2020 | 99 |
| Q4 2020 | 142 |
| Q1 2021 | 130 |
| Q2 2021 | 115 |
| Q3 2021 | 121 |
| Q4 2021 | 130 |
| Q1 2022 | 136 |
| Q2 2022 | 118 |
| Q3 2022 | 135 |
| Q4 2022 | 159 |
| Q1 2023 | 90 |
Hedge funds changes in Syndax Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 22 | 27 | 20 | 10 | 4 |
|---|---|---|---|---|---|
| Q3 2018 | 13 | 28 | 19 | 22 | -8 |
| Q4 2018 | 15 | 25 | 22 | 16 | -5 |
| Q1 2019 | 8 | 21 | 21 | 14 | 3 |
| Q2 2019 | 11 | 32 | 13 | 6 | 8 |
| Q3 2019 | 9 | 26 | 14 | 8 | 14 |
| Q4 2019 | 16 | 21 | 21 | 11 | 2 |
| Q1 2020 | 22 | 27 | 25 | 11 | -3 |
| Q2 2020 | 29 | 47 | 12 | 15 | -7 |
| Q3 2020 | 16 | 28 | 36 | 13 | 6 |
| Q4 2020 | 55 | 50 | 24 | 11 | 2 |
| Q1 2021 | 13 | 55 | 43 | 25 | -6 |
| Q2 2021 | 11 | 54 | 31 | 26 | -7 |
| Q3 2021 | 19 | 38 | 39 | 13 | 12 |
| Q4 2021 | 29 | 42 | 34 | 19 | 6 |
| Q1 2022 | 28 | 53 | 30 | 22 | 3 |
| Q2 2022 | 11 | 47 | 35 | 24 | 1 |
| Q3 2022 | 26 | 62 | 27 | 11 | 9 |
| Q4 2022 | 33 | 66 | 38 | 9 | 13 |
| Q1 2023 | 18 | 42 | 15 | 13 | 2 |
Hedge funds changes in Syndax Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 387,000 | 448,000 |
|---|---|---|
| Q3 2018 | 4,805,000 | 755,000 |
| Q4 2018 | 2,051,000 | 290,000 |
| Q1 2019 | 350,000 | 50,000 |
| Q2 2019 | 929,000 | 621,000 |
| Q3 2019 | 3,391,000 | 3,025,000 |
| Q4 2019 | 3,599,000 | 1,225,000 |
| Q1 2020 | 6,231,000 | 226,000 |
| Q2 2020 | 13,148,000 | 2,785,000 |
| Q3 2020 | 1,120,000 | 1,242,000 |
| Q4 2020 | 8,491,000 | 3,480,000 |
| Q1 2021 | 5,552,000 | 3,817,000 |
| Q2 2021 | 1,311,000 | 1,988,000 |
| Q3 2021 | 894,000 | 389,000 |
| Q4 2021 | 5,766,000 | 825,000 |
| Q1 2022 | 1,555,000 | 21,000 |
| Q2 2022 | 3,845,000 | 381,000 |
| Q3 2022 | 5,432,000 | 442,000 |
| Q4 2022 | 2,768,235 | 2,564,815 |
| Q1 2023 | 631,498,000 | 1,888,128,000 |